Skip to main content
. 2021 Apr 7;13(4):1212. doi: 10.3390/nu13041212

Figure 3.

Figure 3

TNBC miRNA therapeutic strategy. Inhibiting the function of OncomiR by the use of miRNAs suppression and promoting the activity of tumor suppressor miRNAs through miRNA mimics can serve as novel therapeutic options against TNBC.

HHS Vulnerability Disclosure